Canadian medical cannabis patients who kept authorization had better outcomes than unauthorized users | Research

The takeaway

Among 5,433 Canadians using cannabis therapeutically after recreational legalization, those who maintained medical authorization were more likely to use regulated sources, know their dosing, report fewer side effects, and consult healthcare professionals.

Medical cannabis patients, healthcare providers, cannabis policy makers in legalized jurisdictions

74% vs. 48% used regulated sources

What the researchers found

Authorized patients were more likely to report no side effects (29.9% vs. 23.4%), know their cannabis amounts (32.1% vs. 17.7%), obtain from regulated sources (74.1% vs. 47.5%), and seek info from healthcare professionals (67.8% vs. 48.2%).

Why it matters

With many patients leaving the medical cannabis system after recreational legalization, this study suggests the medical authorization process provides tangible benefits including better product knowledge, fewer side effects, and professional guidance.

The numbers in context

5,433 respondents, 2,941 (54.1%) with authorization. No side effects: 29.9% vs. 23.4% (p<0.001). Knew amount: 32.1% vs. 17.7% (p<0.001). Regulated sources: 74.1% vs. 47.5% (p<0.001). Healthcare professional info: 67.8% vs. 48.2% (p<0.01).

How the study worked

Online survey of 5,433 Canadians using cannabis therapeutically in early 2022 (54.1% held medical authorization). Multivariable logistic regression assessed factors associated with authorization status.

What this study cannot tell us

Self-selected survey sample may overrepresent engaged patients. Cross-sectional design cannot determine whether authorization causes better outcomes or whether more health-conscious patients seek authorization. Online survey excludes those without internet access.

How to read the evidence

Large survey with multivariate analysis, but self-selected sample and cross-sectional design limit causal conclusions.

When this study was published

2024 survey of Canadian therapeutic cannabis users in early 2022

The bigger picture

The decline in medical cannabis authorizations post-legalization may mean many therapeutic users are losing the benefits of professional guidance and regulated product access. This has implications for patient safety and health outcomes.

Questions still open

Should medical cannabis programs be strengthened to retain patients even after recreational legalization? Would integrating medical cannabis into routine healthcare improve outcomes for unauthorized therapeutic users?

Common questions

Why does medical authorization matter if cannabis is legal recreationally?

This study found authorized patients had fewer side effects, better dosing knowledge, used regulated sources more often, and consulted healthcare providers more frequently, suggesting the medical process provides practical benefits beyond legal access.

Who was more likely to have medical authorization?

Older individuals, those with higher income, and urban residents were more likely to maintain authorization. Those in small towns or rural areas were less likely.

Read the original research

Canadians' use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status.

BMC medicine, 22(1), 150

View on PubMed ↗Publisher’s paper ↗

Citation

Balneaves, Lynda G; Brown, Ashleigh; Green, Matthew; Prosk, Erin; Rapin, Lucile; Monahan-Ellison, Max; McMillan, Eva; Zaid, Jonathan; Dworkind, Michael; Watling, Cody Z. (2024). Canadians' use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status.. BMC medicine, 22(1), 150. https://doi.org/10.1186/s12916-024-03370-7